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Abstract
Background: To gain insight into the transmission of tuberculosis (TB) in peri-urban Kampala-Uganda, we performed a
household contact study using children as a surrogate for recent transmission of Mycobacterium tuberculosis (MTB).
Using this approach, we sought to understand M. tuberculosis complex (MTBC) lineage diversity, distribution and how
these relate to TB transmission to exposed children.
Method: MTBC isolates from children aged≤ 15 years, collected from 2002 to 2010 in a household-contact study, were
analyzed using a LightCycler RT-PCR SNP genotyping assay (LRPS). The resultant genotypic data was used to determine
associations between MTBC lineage and the children’s clinical and epidemiological characteristics.
Results and discussion: Of the 761 children surveyed, 9 % (69/761) had culture-positive TB an estimate in the
range of global childhood TB; of these 71 % (49/69) were infected with an MTBC strain of the “Uganda family”,
17 % (12/69) infected with MTBC lineage 4 strains other than MTBC Uganda family and 12 % (8/69) infected with
MTBC lineage 3, thereby disproportionately causing TB in the study area. Overall the data showed no correlation
between the MTBC lineages studied and transmission (OR = 0.304; P-value = 0.251; CI: 95 %; 0.039-2.326) using
children a proxy for TB transmission.
Conclusions: Our findings indicate that MTBC Uganda family strains are the main cause of TB in children in peri-urban
Kampala. Furthermore, MTBC lineages did not differ in their transmissibility to children.
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Background
Inhalation of aerosols containing Mycobacterium tuber-
culosis (MTB) bacilli by susceptible hosts is the main
route of transmission of tuberculosis (TB), a disease that
causes high mortality and morbidity with an estimated
74,000-130,000 cases in children and 1.5 million deaths
per annum in adults [1–4]. Under certain circumstances,
TB can also be vertically transmitted, i.e. congenital TB
[1, 5]. A number of risk factors have been associated
with MTB transmission. For instance such factors may
be host related such as HIV co-infection, age, sex [6, 7]
[8]; some are environmental such as overcrowding [9].
Moreover, MTBC strains may differ in virulence and
transmissibility [4, 10–13]. Two approaches have been
used to define MTB transmission in a community. The
first uses MTBC phylogenetic clustering to signify on-
going transmission (recent transmission) and the presence
of unique strains as indicators of reactivation of latent TB
infections [4, 14, 15]. A second approach defines transmis-
sion through pediatric TB, since children progress faster
from recent MTB infection to disease than adults, in part
because of immune system immaturity resulting in rapid
disease progression rather than latency [16–18].
Like any other Sub-Saharan country, Uganda has a
diversity of MTBC lineages with the MTBC Uganda
family, a sub-lineage of lineage 4 (Euro-American
lineage) being the main cause of TB followed by MTBC
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lineage 4 non-Uganda (Euro American lineages other
than Uganda family) and MTBC lineage 3 (East Africa
India/Central Asian Strain) [13]. Studies on transmission
dynamics of these MTBC lineages in Uganda are not
well described, yet could shed light on the relative distri-
bution and dominance of the MTB Uganda family. For
instance, the wide spatial distribution and dominance of
the Beijing genotype, a member of MTBC lineage 2 (East
Asia lineage), has been associated with increased trans-
missibility relative to other MTBC lineages in certain
geographical regions [10, 11, 19]. These studies were
done in adults where it is difficult to ascertain when
transmission occurred [15]. Children on the other hand,
negate this impediment since primary active disease pro-
gression is common due to a less developed TB specific
immunity. Thus children provide an alternative model
for studying on-going transmission of MTB.
In this study, childhood TB was used as a proxy for
transmission in an effort to understand why the MTBC
Uganda family has been dominant in peri-urban Kampala
over several decades [20]. We hypothesized that the MTB
Uganda family is more transmissible than other MTBC
lineages circulating in peri-urban Kampala. To test this
hypothesis, MTBC isolates from children aged ≤ 15 years
were collected from a household cohort conducted from
2002 to 2010 as described by Jaganath et al., [21] and ana-
lyzed to understand the MTBC lineage distribution among
the pediatric TB cases. In addition we examined the asso-
ciation between MTBC lineages and certain epidemio-
logical and clinical variables.
Materials and methods
Study area and sample collection
Children in contact with adults who had pulmonary TB in
peri-urban Kampala were studied. The study considered
MTBC isolates that were collected from children aged ≤
15 years using a well characterized TB household contact
study conducted in the Kawempe area of Kampala, the
Kawempe Community Household study (KC) [20]. The
KC study focused on TB and its risk factors among adult
patients (≥18) and their household contacts. Culture posi-
tive TB patients were consecutively enrolled as index
cases (patient who reported first at the TB clinic with pul-
monary TB) and their housemates (contacts) whom had
stayed in the index case household for at least 7 consecu-
tive days during the 3 months prior to the diagnosis of
TB. Household contacts were classified as co-prevalent
cases if active TB was present at baseline or during three
months of household follow-up and as incident cases if
active TB developed after three months of follow-up.
At baseline, data of enrolled children, including age,
sex, HIV status and presence of BCG scar (deltoid scar)
were recorded. Clinical features such as persistent cough
for more than 3 weeks, night sweats and hemoptysis were
documented. The radiological features such as extent of
lung involvement classified as (i) normal/moderate [mild
lung disease], where lesions appeared as infiltrates of slight
to moderate densities affecting a small portion of one or
both lungs with no cavitation (ii) advanced/far advanced
[advanced lung disease], where lung lesions were more ex-
tensive than in mild lung disease category with cavities ≤
4 cm, were documented. Tuberculin skin test (TST) was
performed by Mantoux method (where a positive TST
was defined as an induration of ≥ 10 mm if a child was
HIV negative and ≥ 5 years of age or ≥ 5 mm if a child was
HIV positive or < 5 years of age). Sputum or gastric lavage
samples collected at baseline were microscopically exam-
ined and processed for culture at the Joint Clinical Research
Centre (JCRC) TB Laboratory in Kampala following stand-
ard procedures [22]. Isolates were confirmed as MTBC
using the BACTEC® para-nitro-acetyl amino-hydroxy-
propiophenone (NAP) susceptibility method [23] after
4 weeks and stored at – 80 °C in 7H9 broth supplemented
with OADC and glycerol for future analysis. In this study, a
total of 761 children from 351 households were enrolled.
Of these, 69 (9 %) were culture positive and had their bacilli
isolated and stored for future use. In an earlier study, a total
of 1746 isolates from adult (>15 years) patients within the
same cohort were genotyped as described [13].
Genomic DNA extraction from stored MTBC isolates
A total of 69 isolates were stored in replicates at – 80 °C.
Isolates corresponding to an individual child were selected
for genotyping. To extract DNA, the selected isolates
were thawed overnight at – 20 °C and later at room
temperature for 12 hours. The vials were centrifuged at
15,000 g for 30 min and the pellet washed twice with
500 μl of Qiagen PCR-grade water. The final pellet was re-
suspended in 100 μl of Qiagen PCR-water, heated at 95 °C
for 30 minutes to kill and lyse the bacilli and later soni-
cated for 15 min at room temperature. The extracted
crude genomic DNA in the supernatant was recovered by
centrifugation at 15,000 g for 30 min; the latter was used
immediately in the real time PCR (RT-PCR) assay or
stored at −20 ° C for future use.
Genotyping the MTBC isolates from children
To ascertain the MTBC lineage to the 69 isolates, three
single nucleotide polymorphism (SNP) markers were
used. These are specific for identifying MTBC Uganda
family (MTB L4-U), MTBC Lineage 4 and MTBC
Lineage 3 (MTBC L3). Corresponding primers and
probes were used in a LightCycler real time PCR SNP
assay (LRPS) to identify the MTBC lineages on the basis
of differences in melting temperature (Tm) as described
by Wampande et al. [13]. In all the assays, we used MTB
L4-U genomic DNA from our laboratory, H37Rv gen-
omic DNA (Lineage 4) and MTB Lineage 3 (Central
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Asian strain) genomic DNA (Courtesy of Mark Nicol) as
positive control DNA.
Statistical analysis
The baseline characteristics of children with TB were
compared with MTBC lineage using the chi-square test
for binary data. A series of univariate and multivariable
logistic regression models were fitted to evaluate the re-
lationship between MTBC lineage (main exposure vari-
able) and extent of lung involvement of TB disease
(either Normal/moderate [mild lung disease]; or ad-
vanced/far advanced [advanced lung disease] on chest
radiograph as the outcome [24]. The extent of lung in-
volvement i.e. normal/moderate (mild lung disease) or
advanced/far advanced (advanced lung disease) was used
as a measure of disease severity and hence transmission
[10, 12, 25]. The covariates age, sex, HIV status, pres-
ence of BCG scar, night sweats, hemoptysis, tuberculin
skin test, and cough were used as adjusters. All analyses
were performed using STATA version 12.
Ethical consideration
The institutional review boards and ethics committees at
Case Western Reserve University, Makerere University,
Uganda AIDS Research Council, and the Uganda National
Council for Science and Technology approved the study
protocols. Patients/guardians gave written consent for the
children and children aged ≥ 8 years provided additional
assent. Pre- and post-HIV test counseling was provided.
Results
Characteristics of children with culture positive
tuberculosis
A total of 761 children (from 351 household) were sur-
veyed from 2002 to 2010 in a household study. Of these,
69 (9 %) children (from 62 household) were culture posi-
tive, this finding is similar to earlier studies carried out
in the same study cohort [21]. Seventy-one percent (49/
69) were children aged up to 5 years, 54 % (37/69) were
females, 14 % (9/66) were HIV positive, 67 % (46/69) had
a BCG scar, 12 % (8/69) reported signs of night sweating,
29 % (19/65) showed advanced lung disease on radiog-
raphy, 42 % (29/69) had cough, 62 % (41/66) had a posi-
tive tuberculin skin test and 85 % (47/55) were smear
negative (Table 1). Furthermore, 91 % (59/62) had no cavi-
tation, and 97 % (67/69) also had no hemoptysis.
MTBC lineages infecting children in peri-urban Kampala
All 69 MTB isolates corresponding to an individual
child were genotyped using LRPS as described by
Table 1 Distribution of MTBC family among different pediatric TB risk factors
Variable Category Patients characteristics
(N = 69)
MTB Uganda





Age1 0-2years 30(43) 19(39) 11(55) 0.230
2-5years 19(28) 13(27) 6(30)
5 above 20(29) 17(35) 3(15)
Sex2 Female 37(54) 27(55) 10(50) 0.451
Male 32(46) 22(45) 10(50)
HIV status3 Negative 57(86) 40(85) 17(89) 0.489
Positive 9(14) 7(15) 2(11)
BCG scar4 Absent 23(33) 18(37) 15(75) 0.259
Present 46(67) 31(63) 5(25)
Night sweats5 Absent 61(88) 42(86) 19(95) 0.259
Present 8(12) 7(14) 1(5)
Extent of lung involvement6 Normal/Moderate 46(71) 36(78) 10(53) 0.041
Advanced/Far Advanced 19(29) 10 (22) 9 (47)
Cough7 No 40(58) 32(65) 8(40) 0.048
Yes 29(42) 17(35) 12(60)
Tuberculin skin test8 Negative 25(38) 21(45) 4(21) 0.063
Positive 41(62) 26(55) 15(79)
Smear status9 Negative 47(85) 30(79) 17(100) 0.041
Positive 8(15) 8(21) 0(0)
1,2,4,5,7 =Age, Sex, BCG scar, Night sweats and Cough missing 0 values 3 = HIV status missing 3 values, 6 = extent of lung involvement missing 4 values, 8 = tuberculin
skin test missing 3 values and 9 = smear status missing 14 values
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Wampande et al. [13]. Overall, 71 % (49/69) were MTBC
L4-U (MTBC Uganda family), 17 % (12/69) MTBC L4-
NU (Lineage 4 strains other than Uganda family) and
12 % (8/69) Linage 3 (MTBC L3). This data was compar-
able with MTBC lineages in the adult (≥18 years) patients
published by Wampande et al. [13] from the same study
cohort. Given that finding, further analysis was done to
seek for possible association between MTBC lineages and
the available clinical and epidemiological variables.
The additional data analysis (this analysis has combined
MTB L4-NU and MTB L3 in one group: from now
onwards this shall be referred to as MTBC non-Uganda)
showed that children infected with MTBC non-Uganda
lineage were more likely to have cough (P = 0.048) and ad-
vanced extent (Advance/far advanced) of lung involve-
ment (P = 0.041) compared to those infected with MTBC
Uganda family. Children infected with MTBC Uganda
were more likely to have smear-positive TB (P = 0.041).
No significant differences (P > 0.05) were observed between
MTBC lineages with respect to age, sex, HIV/TB co-infec-
tion, presence of a BCG scar, night sweats and
tuberculin skin test status (Table 1).
Risk factors associated with advanced lung disease
in children
Since advanced lung disease is positively correlated with
severity of disease and hence a measure of transmissibility
[10–12, 25, 26], we looked for differences in transmissibil-
ity among MTBC lineages, using advanced extent of lung
involvement (mild or advanced lung disease) as the
outcome in the logistic model. Multivariate analysis was
performed to look for risk factors associated with ad-
vanced lung disease while using MTBC lineage as the
main predictor. After adjusting for age, sex, HIV status,
presence or absence of BCG scar, a child having or not
having night sweats, children who cough and those who
do not, data showed that the odds of a child having
advanced lung disease did not differ significantly (OR =
0.304, CI: 95 %; 0.039-2.326, P = 0.251) between MTBC
lineages and no other risk factor was associated with
advanced lung disease (Table 2).
Discussion
In this study, genotypic data of MTBC isolates in com-
bination with epidemiological and clinical data from
children (≤15 years) was used to describe on-going TB
transmission in peri-urban Kampala. The findings indi-
cate that 9 % of children in peri-urban Kampala in this
TB household contact study had culture confirmed TB
and presented with paucibacillary TB, no cavitation and
no hemoptysis as described by others [4, 16, 27, 28]. The
current study had more patients analyzed compared to
those described by Jaganath et al. [21] this is as a result
a longer follow-up. However the TB prevalence between
the 2 studies did not differ significantly. Moreover, this
data found cough and extent of lung involvement signifi-
cantly associated with MTB lineages but this disappeared
in the multivariate analysis [29, 30]. The distribution of
MTBC lineages in peri-urban Kampala between adults
and children was similar, with MTBC L4-U as the most
dominant, followed by MTBC L4-NU and MTBC L3.
Table 2 Multivariate analysis for factors associated with advanced lung disease among 69 pediatric TB cases
Category Crude value Adjusted value
OR; (95 % CI) P values OR (95 % CI) P values
MTB genotypes MTB Non-Uganda 1 0.043 1 0.251
MTB Uganda 0.308 (0.099-0.966) 0.304 (0.039-2.326)
Age ≤5 years 1 0.081 1 0.059
>5 years 0.243(0.049-1.192) 0.065 (0.004-1.111),
Sex Female 1 0.900 1 0.677
Male 1.071 (0.367-3.128) 1.405 (0.283-6.969),
HIV status Negative 1 0.977 1 0.307
Positive 0.975 (0.171-5.555) 0.242 (0.0158-3.695)
BCG Scar Absent 1 0.219 1 0.307
Present 2.198 (0.627-7.711), 1.075 (0.202-5.715)
Night sweats No 1 0.102 1 0.049
Yes 3.822 (0.765-19.09) 20.809 (1.013-427-229)
Cough No 1 0.246 1 0.174
Yes 1.895(0.643-5.589) 0.231(0.279-1.913)
Tuberculin skin test Negative 1 0.071 1 0.148
Positive 3.150(0.906-10.953) 5.140 (0.558-47.322)
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MTBC lineages did not differ in capacity to transmit or
cause advanced lung disease in children.
Our data shows 9 % (69/761) childhood TB. Studies
elsewhere demonstrate 1 % - 4 % using smear positive
cases [4, 31, 32], contact investigation studies estimated
a prevalence of 7 % -10 % [21, 33, 34] in a high TB burden
setting and 5 % in low-burdened countries [32, 35].
Current global childhood TB estimates range from
10–15 % [35, 36], which is close to our findings.
The MTBC lineage distribution pattern in children
and adults was similar consistent with adult to child TB
transmission in a household. A related study in peri-urban
Kampala demonstrated transmission between members of
the same residence since they had similar strains [37].
77 % (48/62) of the residences showed children infected
with the same MTBC lineages as the adults, the other
23 % showing heterogeneous MTBC lineages suggesting
community transmission from adult to children. Never-
theless, we cannot rule out the possibility that some chil-
dren acquired more than one MTBC lineage from the
adults. Indeed, similar studies in the study area showed
that 7.1 % of the patients were infected with more than
one strain [38]. Studies elsewhere indicate that the com-
munity is the main vehicle for MTB transmission [39–43].
However, this is contrary to our current results. Perhaps
community transmission is more common in high TB
incidence regions where chances of acquiring the
infection outside are higher than inside the household
[44]. This data shows that intra family and community TB
transmission are important mechanisms of disease spread
in this study.
Transmission of TB in children is a reflection of on-
going transmission of MTB in a community [45]. This
study used children as a proxy for transmission, to test the
hypothesis that MTBC L4-U causes advanced lung disease
and thus more transmissible [10–12, 25, 26, 46, 47] than
other lineages circulating in peri-urban Kampala. Ad-
vanced lung disease was defined as the ability of MTBC
lineage to cause extensive lung lesions and cavities ≤ 4 cm
(extensive lung parenchymal damage) as described [24].
The data showed that the odds of causing advanced extent
of lung disease by different MTBC lineages identified in
this study area did not differ significantly (OR = 0.304,
CI: 95 %; 0.039-2.326, P = 0.251) between MTBC line-
ages (Table 2). This lack of association remained even
after adjusting for clinical and epidemiological characteris-
tics of the children. These analyses suggest that MTBC
lineages circulating in peri-urban Kampala are equally
transmissible.
Limitations that of our study are that pediatric TB is a
pauci-bacillary disease. This can lead to significant selec-
tion bias due to variability in culture of MTBC lineages.
However, this was unlikely the case here as the distribu-
tion of MTB strains in children and adults was the same.
Second, the samples size was limited and we therefore
might have missed, true associations. Last, the inability
of SNP markers to resolve the lineages furthers into
strains, precluded us from defining actual chains of
transmission. Nevertheless SNPs are robust markers in
defining MTBC lineages.
Conclusion
Our findings indicate that the majority of childhood TB
is caused by MTBC Uganda family strains in Kampala,
Uganda. There was no evidence that MTBC Uganda
family differed in their propensity to transmit to children
compared to other MTBC lineages.
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